| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 06/05/2007 | US7226741 Multimerization of HIV-1 Vif protein as a therapeutic target |
| 06/05/2007 | US7226591 Nucleotide sequences coding protein for use in the prevention and treatment of pancreatitis |
| 05/31/2007 | WO2007060979A1 Lipopolysaccharide- or lipid a-binder, and novel peptide |
| 05/31/2007 | WO2007060769A1 Lipopolysaccharide or lipid a binder and novel peptide |
| 05/31/2007 | WO2007060524A1 Compounds for the inhibition of apoptosis |
| 05/31/2007 | WO2007059921A1 Solution-phase synthesis of leuprolide and its intermediates |
| 05/31/2007 | WO2007059852A1 Ph-switchable transmembrane peptides as stimulators of membrane fusion |
| 05/31/2007 | WO2007026120A3 Preprotachykinin enhancer elements |
| 05/31/2007 | WO2006135930A3 Transmucosal delivery of peptide derivatives |
| 05/31/2007 | WO2006039668B1 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection |
| 05/31/2007 | WO2005117940A3 Cell death modulation via antagonists of fasl and fas activation |
| 05/31/2007 | US20070124825 Use of hepcidin as a regulator of iron homeostasis |
| 05/31/2007 | US20070123696 G-csf conjugates |
| 05/31/2007 | US20070123468 Prodrugs of active agents |
| 05/31/2007 | US20070123467 Amniotic-derived peptide and uses thereof |
| 05/31/2007 | US20070123454 Contact Inhibitory Factor (CIF) mediated inhibition of tumor metastasis and angiogenesis |
| 05/31/2007 | US20070122863 Incubating substrate for enzyme comprising covalently linked modules including fluorescent reporter molecule; molecular weight-sensitive; high throughput drug screening |
| 05/31/2007 | US20070122424 Peptide-based vaccine for influenza |
| 05/31/2007 | CA2631443A1 Potent compstatin analogs |
| 05/31/2007 | CA2630926A1 Compounds for the inhibition of apoptosis |
| 05/30/2007 | EP1790657A1 pH-switchable transmembrane peptides as stimulators of membrane fusion |
| 05/30/2007 | EP1790656A1 Solution-phase synthesis of leuprolide |
| 05/30/2007 | EP1790655A2 Biologically active peptides |
| 05/30/2007 | EP1790654A1 Peptide capable of binding to insulin-binding protein and adsorbent |
| 05/30/2007 | EP1789436A1 Antibacterial peptides and analogues thereof |
| 05/30/2007 | EP1789081A2 Treatment of atherosclerosis |
| 05/30/2007 | EP1789069A2 Cyclic peptides for treatment of cachexia |
| 05/30/2007 | EP1429763B1 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 05/30/2007 | EP0726954B2 Cytokine antagonists |
| 05/30/2007 | CN1973053A Novel anti-IL 13 antibodies and uses thereof |
| 05/30/2007 | CN1972960A Processes for preparing eptifibatide |
| 05/30/2007 | CN1972957A Potassium channel regulating pepetide |
| 05/30/2007 | CN1970078A Peptides and related molecules that bind to tall-1 |
| 05/30/2007 | CN1970077A Peptides and related molecules that bind to tall-1 |
| 05/30/2007 | CN1318652C Continuous electrolytic pickling method for metallic products using alternate current supplied cells |
| 05/30/2007 | CN1318447C Tumor antigen peptides originating in cyclophilin B |
| 05/30/2007 | CN1318445C Process for the preparation of bicyclic peptide compounds |
| 05/30/2007 | CN1318084C Neuroprotective peptides |
| 05/29/2007 | US7223854 Transfecting or infecting cells and culturing; purified polypeptide, for use in diagnosis |
| 05/29/2007 | US7223835 Cyclic peptide mimetic for treating cancer; anticarcinogenic agents |
| 05/29/2007 | US7223734 Comprises peptide which binds to fibrinogen and serves as a modulator of enzyme activity; for increasing the half- life of proteins and pro-drugs in circulation; for treatment of arteriosclerosis and emphysema |
| 05/24/2007 | WO2007057648A1 Inhibitors of bcl-6 |
| 05/24/2007 | WO2007057141A1 Process and intermediates for the synthesis of caspofungin |
| 05/24/2007 | WO2007037133A9 Method for evaluation of compound capable of acting on plk3 |
| 05/24/2007 | WO2006087550A3 Amyloid-binding peptides, analogues and uses thereof |
| 05/24/2007 | WO2005107357A3 Analgesic peptides derived from the venom of crotalus durissus terrificuss snakes |
| 05/24/2007 | US20070117758 Treating treating angiogenic disease, e.g., cancer, by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester |
| 05/24/2007 | US20070117746 Treatment of viral infections |
| 05/24/2007 | US20070117743 New antitumoral compounds |
| 05/24/2007 | US20070117154 Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery |
| 05/24/2007 | US20070117150 Carbon nanotube binding peptides |
| 05/24/2007 | US20070117149 Carbon nanotube binding peptides |
| 05/24/2007 | US20070117148 A solid substrate of CNT having a bonded coating of a peptide having an amino acid sequence consisting of SEQ ID Nos: 1-10; used in separation and immobilization of these structures for the fabrication of nano-devices; uniformity; purification |
| 05/24/2007 | US20070117147 Carbon nanotube binding peptides |
| 05/24/2007 | US20070116644 Detectable labeled cobalamin (adenosylcolbalamin) conjugated with peptidesor amino acid residues linked to a chelate compound (ETDA) including a metal radionuclide;antitumor, anticarcinogenic agents; contrast agent for imaging; diagnosis; nontoxic;bioavailability; detectable at low concentrations |
| 05/24/2007 | CA2626921A1 Process and intermediates for the synthesis of caspofungin |
| 05/23/2007 | EP1788394A1 Screening for peptides inhibiting PP1c binding to Bcl-2, BCL-Xl and BCL-W proteins |
| 05/23/2007 | EP1788074A1 Novel strains belonging to the genus paenibacillus and method of controlling plant disease by using these strains or culture thereof |
| 05/23/2007 | EP1786380A1 Peptide-based body surface reagents for personal care |
| 05/23/2007 | EP1730168A4 Functional method for generating or screening for ligands which modulate steroid hormone receptors |
| 05/23/2007 | CN1969046A Peptide substrates recognisable by a botulinum toxin A, BoNT/A and the use thereof |
| 05/23/2007 | CN1968961A Process for the preparation of peptides |
| 05/23/2007 | CN1968700A Polymer-based sustained release device |
| 05/23/2007 | CN1966529A Recombinant toxin agent containing gonadorelin and pyocyanin functional frament |
| 05/23/2007 | CN1966521A Suppressing peptide of heptitis B virus polymerase lymerase protein YMDD functionalized area and its uses |
| 05/23/2007 | CN1966520A Peptides and compounds that bind to a receptor |
| 05/23/2007 | CN1966516A Nanometre collagen oligopeptide and its producing method |
| 05/22/2007 | US7220832 Dermacentor variabilis GABA-gated chloride channels |
| 05/22/2007 | US7220827 Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient |
| 05/22/2007 | US7220823 A 710 amino acid protein containing 13 transmembrane domains and bearing homology to murine and C. elegans genes containing 12 transmembrane domains |
| 05/22/2007 | US7220822 CD28 mimetics for blocking T cell mediated immune reactions |
| 05/22/2007 | US7220725 Pharmaceutical composition comprising an analgesic peptide and method for treating pain |
| 05/22/2007 | US7220720 Melanin-concentrating hormone analogs |
| 05/22/2007 | US7220420 Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
| 05/22/2007 | CA2143187C Anti-feline immunodeficiency virus (fiv) vaccines |
| 05/22/2007 | CA2111645C Fibrinogen fragment e peptides and antibodies thereto |
| 05/22/2007 | CA2100559C Domains of extracellular region of human platelet derived growth factor receptor polypeptides |
| 05/22/2007 | CA2073045C A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
| 05/18/2007 | WO2007056441A2 Binding polypeptides with diversified and consensus vh/vl hypervariable sequences |
| 05/18/2007 | WO2007055578A1 Cyclic antimicrobial peptides derived from lactoferrin |
| 05/18/2007 | WO2007000036A3 Use of mas g-protein-coupled receptor agonists and antagonists as apoptotic activity modulators for prevention and treatment of diseases |
| 05/18/2007 | WO2006131749A3 Scaffold |
| 05/18/2007 | WO2003077872A3 Cell surface tropomyosin as a target of angiogenesis inhibition |
| 05/18/2007 | CA2626831A1 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating hormonal imbalance |
| 05/17/2007 | US20070112174 Screening; peptide, bacteriophage, artificial protein or chimeric molecule having binding ability to titanium, silver, silicon; expressing library of peptide sequences, recovering titanium bound to phage particles via peptide sequence by centrifuging; proliferation in bacteria, cloning, concentrating |
| 05/17/2007 | US20070111948 Agent derived from tortoise spleen stimulating mammalian hemopoiesis |
| 05/17/2007 | US20070111947 Fibrin targeted therapeutics |
| 05/17/2007 | US20070111946 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) |
| 05/17/2007 | US20070111930 Process for preparing vapreotide |
| 05/17/2007 | US20070111928 Didemnin analogs and fragments and methods of making and using them |
| 05/17/2007 | US20070111927 Peptoid compounds |
| 05/17/2007 | US20070110769 Clostridial toxin derivatives and methods for treating pain |
| 05/16/2007 | EP1785432A1 Process and intermediates for the synthesis of caspofungin. |
| 05/16/2007 | EP1784210A2 Carrier conjugates of gnrh-peptides |
| 05/16/2007 | EP1415006B1 Assay for identifying inhibitors of hiv rt dimerization |
| 05/16/2007 | EP1390406B1 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 05/16/2007 | EP1203019B1 Peptides containing n-substituted l-amino acids for preventing beta-strand association |
| 05/16/2007 | EP1169340B1 Lantibiotic |
| 05/16/2007 | EP1085896B1 Conformationally constrained backbone cyclized somatostatin analogs |
| 05/16/2007 | CN1316016C Novel enzyme forming peptide, microorganism producing the same and process for producing dipeptide using them |